These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 32793150)

  • 1. The Butyrogenic and Lactic Bacteria of the Gut Microbiota Determine the Outcome of Allogenic Hematopoietic Cell Transplant.
    Devaux CA; Million M; Raoult D
    Front Microbiol; 2020; 11():1642. PubMed ID: 32793150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of Gut Microbiota Composition and Diversity in Acute and/or Chronic Graft-versus-Host Disease Following Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study.
    Gavriilaki E; Christoforidi M; Ouranos K; Minti F; Mallouri D; Varelas C; Lazaridou A; Baldoumi E; Panteliadou A; Bousiou Z; Batsis I; Sakellari I; Gioula G
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
    Staffas A; Burgos da Silva M; van den Brink MR
    Blood; 2017 Feb; 129(8):927-933. PubMed ID: 27940475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of the intestinal microbiome to immune recovery after HCT.
    Wolfe AE; Markey KA
    Front Immunol; 2022; 13():988121. PubMed ID: 36059482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
    Ingham AC; Kielsen K; Mordhorst H; Ifversen M; Aarestrup FM; Müller KG; Pamp SJ
    Microbiome; 2021 Jun; 9(1):148. PubMed ID: 34183060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
    Parco S; Benericetti G; Vascotto F; Palmisciano G
    Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation.
    Fujiwara H
    Front Immunol; 2021; 12():703298. PubMed ID: 34512627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic Acid Signaling Modulates Recipient Gut Barrier Integrity and Microbiota After Allogeneic Hematopoietic Stem Cell Transplantation in Mice.
    Pan P; Atkinson SN; Taylor B; Zhu H; Zhou D; Flejsierowicz P; Wang LS; Morse M; Liu C; Gunsolus IL; Chen X
    Front Immunol; 2021; 12():749002. PubMed ID: 34759928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged Suppression of Butyrate-Producing Bacteria Is Associated With Acute Gastrointestinal Graft-vs-Host Disease and Transplantation-Related Mortality After Allogeneic Stem Cell Transplantation.
    Meedt E; Hiergeist A; Gessner A; Dettmer K; Liebisch G; Ghimire S; Poeck H; Edinger M; Wolff D; Herr W; Holler E; Weber D
    Clin Infect Dis; 2022 Mar; 74(4):614-621. PubMed ID: 34043764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD.
    Sofi MH; Wu Y; Ticer T; Schutt S; Bastian D; Choi HJ; Tian L; Mealer C; Liu C; Westwater C; Armeson KE; Alekseyenko AV; Yu XZ
    JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients.
    van Lier YF; Davids M; Haverkate NJE; de Groot PF; Donker ML; Meijer E; Heubel-Moenen FCJI; Nur E; Zeerleder SS; Nieuwdorp M; Blom B; Hazenberg MD
    Sci Transl Med; 2020 Aug; 12(556):. PubMed ID: 32801142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Throughput Analysis Reveals Changes in Gut Microbiota and Specific Fecal Metabolomic Signature in Hematopoietic Stem Cell Transplant Patients.
    Kouidhi S; Souai N; Zidi O; Mosbah A; Lakhal A; Ben Othmane T; Belloumi D; Ben Ayed F; Asimakis E; Stathopoulou P; Cherif A; Tsiamis G
    Microorganisms; 2021 Aug; 9(9):. PubMed ID: 34576740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Promising Insight: The Potential Influence and Therapeutic Value of the Gut Microbiota in GI GVHD.
    Li J; Zhang X; Chen Y; Zheng Q; Zhao M; Jiang H
    Oxid Med Cell Longev; 2022; 2022():2124627. PubMed ID: 35571252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation.
    Khuat LT; Le CT; Pai CS; Shields-Cutler RR; Holtan SG; Rashidi A; Parker SL; Knights D; Luna JI; Dunai C; Wang Z; Sturgill IR; Stoffel KM; Merleev AA; More SK; Maverakis E; Raybould HE; Chen M; Canter RJ; Monjazeb AM; Dave M; Ferrara JLM; Levine JE; Longo DL; Abedi M; Blazar BR; Murphy WJ
    Sci Transl Med; 2020 Nov; 12(571):. PubMed ID: 33239390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-versus-host disease propagation depends on increased intestinal epithelial tight junction permeability.
    Nalle SC; Zuo L; Ong MLDM; Singh G; Worthylake AM; Choi W; Manresa MC; Southworth AP; Edelblum KL; Baker GJ; Joseph NE; Savage PA; Turner JR
    J Clin Invest; 2019 Feb; 129(2):902-914. PubMed ID: 30667372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials.
    Noor F; Kaysen A; Wilmes P; Schneider JG
    J Innate Immun; 2019; 11(5):405-415. PubMed ID: 30286447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial.
    Andermann TM; Fouladi F; Tamburini FB; Sahaf B; Tkachenko E; Greene C; Buckley MT; Brooks EF; Hedlin H; Arai S; Mackall CL; Miklos D; Negrin RS; Fodor AA; Rezvani AR; Bhatt AS
    Transplant Cell Ther; 2021 Nov; 27(11):932.e1-932.e11. PubMed ID: 34274493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.